Dianthus Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Dianthus Therapeutics has a total shareholder equity of $337.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $354.2M and $16.4M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$281.12m |
| Equity | US$337.90m |
| Total liabilities | US$16.35m |
| Total assets | US$354.25m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 87E's short term assets ($287.5M) exceed its short term liabilities ($15.7M).
Long Term Liabilities: 87E's short term assets ($287.5M) exceed its long term liabilities ($640.0K).
Debt to Equity History and Analysis
Debt Level: 87E is debt free.
Reducing Debt: 87E has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 87E has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 87E has sufficient cash runway for 2.3 years if free cash flow continues to reduce at historical rates of 44.7% each year.